Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms

被引：102

作者：

Katragkou, Aspasia ^{[1
]}

Chatzimoschou, Athanasios ^{[1
]}

Simitsopoulou, Maria ^{[1
]}

Dalakiouridou, Maria ^{[1
]}

Diza-Mataftsi, Eudoxia ^{[2
]}

Tsantali, Chaido ^{[3
]}

Roilides, Emmanuel ^{[1
]}

机构：

[1] Aristotle Univ Thessaloniki, Dept Pediat 3, Hippokrat Hosp, Infect Dis Lab, GR-54642 Thessaloniki, Greece

[2] Aristotle Univ Thessaloniki, Dept Microbiol 1, Thessaloniki 54124, Greece

[3] Aristotle Univ Thessaloniki, Dept Pediat 1, Hippokrat Hosp, Thessaloniki 54642, Greece

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2008年 / 52卷 / 01期

关键词：

D O I：

10.1128/AAC.00856-07

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The activities of voriconazole, posaconazole, caspofungin, and anidulafungin against Candida albicans and Candida parapsilosis biofilms were evaluated. In contrast to planktonic cells, the MICs for voriconazole and posaconazole for the biofilms of the two species were high (>= 256 and >64 mg/liter, respectively) but relatively low for the echinocandins caspofungin and anidulafungin (<= 1 and <= 2 mg/liter, respectively).

引用

页码：357 / 360

页数：4

共 17 条

[1] In vitro activity of caspofungin against Candida albicans biofilms [J].

Bachmann, SP ;

VandeWalle, K ;

Ramage, G ;

Patterson, TF ;

Wickes, BL ;

Graybill, JR ;

López-Ribot, JL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3591-3596

[2]

Baillie GS, 1999, METHOD ENZYMOL, V310, P644

[3] Paradoxical effect of echinocandins across Candida species in vitro:: Evidence for echinocandin-specific and Candida species-related differences [J].

Chamilos, Georgios ;

Lewis, Russell E. ;

Albert, Nathaniel ;

Kontoyiannis, Dimitrios P. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) :2257-2259

[4] Antifungal resistance of candidal biofilms formed on denture acrylic in vitro [J].

Chandra, J ;

Mukherjee, PK ;

Leidich, SD ;

Faddoul, FF ;

Hoyer, LL ;

Douglas, LJ ;

Ghannoum, MA .

JOURNAL OF DENTAL RESEARCH, 2001, 80 (03) :903-908

[5] Biofilm formation by the fungal pathogen Candida albicans:: Development, architecture, and drug resistance [J].

Chandra, J ;

Kuhn, DM ;

Mukherjee, PK ;

Hoyer, LL ;

McCormick, T ;

Ghannoum, MA .

JOURNAL OF BACTERIOLOGY, 2001, 183 (18) :5385-5394

[6] Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms [J].

Cocuaud, C ;

Rodier, MH ;

Daniault, G ;

Imbert, C .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (03) :507-512

[7] Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus [J].

Dotis, J ;

Simitsopoulou, M ;

Dalakiouridou, M ;

Konstantinou, T ;

Taparkou, A ;

Kanakoudi-Tsakalidou, F ;

Walsh, TJ ;

Roilides, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) :868-873

[8] Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the Standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents [J].

Hawser, SP ;

Norris, H ;

Jessup, CJ ;

Ghannoum, MA .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (05) :1450-1452

[9] Evaluation of endpoints for antifungal susceptibility determinations with LY303366 [J].

Klepser, ME ;

Ernst, EJ ;

Ernst, ME ;

Messer, SA ;

Pfaller, MA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) :1387-1391

[10] Antifungal susceptibility of Candida biofilms:: Unique efficacy of amphotericin B lipid formulations and echinocandins [J].

Kuhn, DM ;

George, T ;

Chandra, J ;

Mukherjee, PK ;

Ghannoum, MA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :1773-1780

← 1 2 →